Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP).
Ruiz-Patiño A, Arrieta O, Cardona AF, Martín C, Raez LE, Zatarain-Barrón ZL, Barrón F, Ricaurte L, Bravo-Garzón MA, Mas L, Corrales L, Rojas L, Lupinacci L, Perazzo F, Bas C, Carranza O, Puparelli C, Rizzo M, Ruiz R, Rolfo C, Archila P, Rodríguez J, Sotelo C, Vargas C, Carranza H, Otero J, Pino LE, Ortíz C, Laguado P, Rosell R; CLICaP. Ruiz-Patiño A, et al. Thorac Cancer. 2020 Feb;11(2):353-361. doi: 10.1111/1759-7714.13272. Epub 2019 Dec 12. Thorac Cancer. 2020. PMID: 31828967 Free PMC article.
Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP).
Ruiz-Patiño A, Barrón F, Cardona AF, Corrales L, Mas L, Martín C, Zatarain-Barrón ZL, Recondo G, Ricaurte L, Rojas L, Archila P, Rodríguez J, Sotelo C, Viola L, Vargas C, Carranza H, Otero J, Pino LE, Rolfo C, Rosell R, Arrieta O; CLICaP. Ruiz-Patiño A, et al. Thorac Cancer. 2020 Sep;11(9):2552-2560. doi: 10.1111/1759-7714.13573. Epub 2020 Jul 24. Thorac Cancer. 2020. PMID: 32705787 Free PMC article.
Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy.
Barrón F, Sánchez R, Arroyo-Hernández M, Blanco C, Zatarain-Barrón ZL, Catalán R, Ramos-Ramírez M, Cardona AF, Flores-Estrada D, Arrieta O. Barrón F, et al. Front Oncol. 2020 Sep 29;10:570233. doi: 10.3389/fonc.2020.570233. eCollection 2020. Front Oncol. 2020. PMID: 33117699 Free PMC article.
Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer.
Peralta-Arrieta I, Trejo-Villegas OA, Armas-López L, Ceja-Rangel HA, Ordóñez-Luna MDC, Pineda-Villegas P, González-López MA, Ortiz-Quintero B, Mendoza-Milla C, Zatarain-Barrón ZL, Arrieta O, Zúñiga J, Ávila-Moreno F. Peralta-Arrieta I, et al. Eur J Cancer. 2022 Jan;160:189-205. doi: 10.1016/j.ejca.2021.10.032. Epub 2021 Nov 26. Eur J Cancer. 2022. PMID: 34844838
Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center.
Vidal-Millan S, Zatarain-Barrón ZL, Daza-Galicia K, Shveid Gerson D, Pichardo-Rojas PS, Salazar-Pigeon A, Wegman-Ostrosky T. Vidal-Millan S, et al. Among authors: zatarain barron zl. Front Oncol. 2024 Jan 8;13:1291286. doi: 10.3389/fonc.2023.1291286. eCollection 2023. Front Oncol. 2024. PMID: 38260834 Free PMC article.
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Chamorro DF, Cardona AF, Rodríguez J, Ruiz-Patiño A, Arrieta O, Moreno-Pérez DA, Rojas L, Zatarain-Barrón ZL, Ardila DV, Viola L, Recondo G, Blaquier JB, Martín C, Raez L, Samtani S, Ordóñez-Reyes C, Garcia-Robledo JE, Corrales L, Sotelo C, Ricaurte L, Cuello M, Mejía S, Jaller E, Vargas C, Carranza H, Otero J, Archila P, Bermudez M, Gamez T, Russo A, Malapelle U, de Miguel Perez D, de Lima VCC, Freitas H, Saldahna E, Rolfo C, Rosell R; CLICaP. Chamorro DF, et al. Among authors: zatarain barron zl. Target Oncol. 2023 May;18(3):425-440. doi: 10.1007/s11523-023-00955-9. Epub 2023 Apr 5. Target Oncol. 2023. PMID: 37017806 Free PMC article.
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP).
Raez LE, Arrieta O, Chamorro DF, Soberanis-Piña PD, Corrales L, Martín C, Cuello M, Samtani S, Recondo G, Mas L, Zatarain-Barrón ZL, Ruíz-Patiño A, García-Robledo JE, Ordoñez-Reyes C, Jaller E, Dickson F, Rojas L, Rolfo C, Rosell R, Cardona AF. Raez LE, et al. Among authors: zatarain barron zl. Front Oncol. 2022 Jul 12;12:904800. doi: 10.3389/fonc.2022.904800. eCollection 2022. Front Oncol. 2022. PMID: 35903685 Free PMC article.
Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses.
Barrios-Bernal P, Zatarain-Barrón ZL, Hernández-Pedro N, Orozco-Morales M, Olivera-Ramírez A, Ávila-Moreno F, Colín-González AL, Cardona AF, Rosell R, Arrieta O. Barrios-Bernal P, et al. Among authors: zatarain barron zl. Pharmaceuticals (Basel). 2022 Jun 24;15(7):786. doi: 10.3390/ph15070786. Pharmaceuticals (Basel). 2022. PMID: 35890085 Free PMC article. Review.
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Cardona AF, Ruiz-Patiño A, Recondo G, Martín C, Raez L, Samtani S, Minata JN, Blaquier JB, Enrico D, Burotto M, Ordóñez-Reyes C, Chamorro DF, Garcia-Robledo JE, Corrales L, Zatarain-Barrón ZL, Más L, Sotelo C, Ricaurte L, Santoyo N, Cuello M, Mejía S, Jaller E, Vargas C, Carranza H, Otero J, Rodríguez J, Archila P, Bermudez M, Gamez T, Cordeiro de Lima V, Freitas H, Russo A, Polo C, Malapelle U, Perez DM, Rolfo C, Viola L, Rosell R, Arrieta O. Cardona AF, et al. Among authors: zatarain barron zl. Clin Lung Cancer. 2022 Sep;23(6):522-531. doi: 10.1016/j.cllc.2022.06.001. Epub 2022 Jun 6. Clin Lung Cancer. 2022. PMID: 35798634
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors.
Rojas L, Mayorga D, Ruiz-Patiño A, Rodríguez J, Cardona AF, Archila P, Avila J, Bravo M, Ricaurte L, Sotelo C, Arrieta O, Zatarain-Barrón ZL, Carranza H, Otero J, Vargas C, Barrón F, Corrales L, Martín C, Recondo G, Pino LE, Bermudez MA, Gamez T, Ordoñez-Reyes C, García-Robledo JE, de Lima VC, Freitas H, Santoyo N, Malapelle U, Russo A, Rolfo C, Rosell R; CLICaP. Rojas L, et al. Among authors: zatarain barron zl. ESMO Open. 2022 Aug;7(4):100500. doi: 10.1016/j.esmoop.2022.100500. Epub 2022 Jun 23. ESMO Open. 2022. PMID: 35753086 Free PMC article.
80 results